CytoDyn Inc.
CYDY
$0.204
$0.0031.49%
OTC PK
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -34.13% | 43.02% | |||
| Depreciation & Amortization | 25.00% | -20.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.98% | 45.49% | |||
| Operating Income | -7.98% | -45.49% | |||
| Income Before Tax | 0.21% | -124.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.21% | -124.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.21% | -124.80% | |||
| EBIT | -7.98% | -45.49% | |||
| EBITDA | -7.97% | -45.62% | |||
| EPS Basic | 0.00% | -125.30% | |||
| Normalized Basic EPS | -4.00% | 0.00% | |||
| EPS Diluted | 0.00% | -126.25% | |||
| Normalized Diluted EPS | -4.00% | -4.17% | |||
| Average Basic Shares Outstanding | 0.56% | 7.61% | |||
| Average Diluted Shares Outstanding | 0.56% | 1.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||